CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 221 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,723 | +22.4% | 467 | 0.0% | 0.00% | – |
| Q2 2023 | $10,391 | +2.7% | 467 | 0.0% | 0.00% | – |
| Q1 2023 | $10,115 | +55.6% | 467 | +45.9% | 0.00% | – |
| Q4 2022 | $6,499 | -27.8% | 320 | -13.0% | 0.00% | – |
| Q3 2022 | $9,000 | +28.6% | 368 | +29.1% | 0.00% | – |
| Q2 2022 | $7,000 | 0.0% | 285 | -14.4% | 0.00% | – |
| Q1 2022 | $7,000 | +133.3% | 333 | +158.1% | 0.00% | – |
| Q4 2021 | $3,000 | +50.0% | 129 | +27.7% | 0.00% | – |
| Q3 2021 | $2,000 | -66.7% | 101 | -60.1% | 0.00% | – |
| Q1 2021 | $6,000 | -98.2% | 253 | -99.0% | 0.00% | -100.0% |
| Q4 2018 | $332,000 | -42.9% | 24,832 | -40.1% | 0.00% | -50.0% |
| Q3 2018 | $581,000 | +16.4% | 41,452 | +30.6% | 0.00% | +33.3% |
| Q2 2018 | $499,000 | -8.6% | 31,751 | -4.4% | 0.00% | -25.0% |
| Q1 2018 | $546,000 | – | 33,211 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |